Chester K. Yarbrough

Chester K. Yarbrough

Auto-generated profile, based on publicly available information

Chester K. Yarbrough

Department of Neurological Surgery, Washington University School of Medicine in St. Louis, St. Louis, Missouri

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
JGJacob K. Greenberg
Jacob K. Greenberg
CYChester K. Yarbrough
Chester K. Yarbrough
ARAlireza Radmanesh
Alireza Radmanesh
JGJakub Godzik
Jakub Godzik
MYMegan Yu
Megan Yu
DLDavid D. Limbrick
David D. Limbrick
BACKGROUND:. To develop evidence-based treatment guidelines for Chiari malformation type 1 (CM-1), preoperative prognostic indices capable of stratifyin

29 April 2014 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
ALAmy Lee
Amy Lee
CYChester K. Yarbrough
Chester K. Yarbrough
JGJacob K. Greenberg
Jacob K. Greenberg
JBJason Barber
Jason Barber
DLDavid D. Limbrick
David D. Limbrick
MSMatthew D. Smyth
Matthew D. Smyth

1 June 2014 in Journal of neurosurgery. Pediatrics
Verified
Journal Article
Open access
PDF file
CYChester K. Yarbrough
Chester K. Yarbrough
JGJacob K. Greenberg
Jacob K. Greenberg
MSMatthew D. Smyth
Matthew D. Smyth
JLJeffrey R. Leonard
Jeffrey R. Leonard
TPTae Sung Park
Tae Sung Park
DLDavid D. Limbrick
David D. Limbrick
Object: Historically, assessment of clinical outcomes following surgical management of Chiari malformation Type I (CM-I) has been challenging due to the lack of a validated instrument for widespread use. The Chicago Chiari Outcome Scale (CCOS) is a novel system intended to provide a less subjective evaluation of outcomes for patients with CM-I. The goal of this study was to externally validate the performance of the CCOS. Methods: Patients undergoing surgery for CM-I between 2001 and 2012 were reviewed (n = 292). Inclusion criteria for this study were as follows: 1) patients receiving primary posterior fossa decompression; 2) at least 5.5 months of postoperative clinical follow-up; and 3) patients ≤ 18 years of age at the time of surgery. Outcomes were evaluated using the CCOS, along with a “gestalt” impression of whether patients experienced significant improvement after surgery. A subgroup of 118 consecutive patients undergoing operations between 2008 and 2010 was selected for analysis of interrater reliability (n = 73 meeting inclusion/exclusion criteria). In this subgroup, gestalt and CCOS scores were independently determined by 2 reviewers, and interrater reliability was assessed using the intraclass correlation coefficient (ICC) and kappa (κ) statistic. Results: The median CCOS score was 14, and 67% of patients had improved gestalt scores after surgery. Overall, the CCOS was effective at identifying patients with improved outcome after surgery (area under curve = 0.951). The interrater reliability of the CCOS (ICC = 0.71) was high, although the reliability of the component scores ranged from poor to good (ICC 0.23–0.89). The functionality subscore demonstrated a low ICC and did not add to the predictive ability of the logistic regression model (likelihood ratio = 1.8, p = 0.18). When analyzing gestalt outcome, there was moderate agreement between raters (κ = 0.56). Conclusions: In this external validation study, the CCOS was effective at identifying patients with improved outcomes and proved more reliable than the authors' gestalt impression of outcome. However, certain component subscores (functionality and nonpain symptoms) were found to be less reliable, and may benefit from further definition in score assignment. In particular, the functionality subscore does not add to the predictive ability of the CCOS, and may be unnecessary. Overall, the authors found the CCOS to be an improvement over the previously used assessment of outcome at their institution.

1 September 2012 in Journal of Neurosurgery
Verified
Journal Article
Closed access
WRWilson Z. Ray
Wilson Z. Ray
CYChester K. Yarbrough
Chester K. Yarbrough
AYAndrew Yee
Andrew Yee
SMSusan E. Mackinnon
Susan E. Mackinnon
The surgical management of lower brachial plexus injuries remains a challenging problem. Although nerve transfers have improved clinical outcomes following brachial plexus injuries, the majority of work has focused on upper trunk injuries. Complete lower plexus injuries often lack suitable donors for either nerve or tendon transfers. The authors describe their experience with isolated lower trunk injuries utilizing the nerve to the brachialis to reinnervate the anterior interosseous nerve.

22 December 2011 in Advances in Orthopedics
Verified
Journal Article
Open access
PDF file
CYChester K. Yarbrough
Chester K. Yarbrough
RMRory K. J. Murphy
Rory K. J. Murphy
WRWilson Z. Ray
Wilson Z. Ray
TSTodd J. Stewart
Todd J. Stewart
Cervical spondylotic myelopathy (CSM) refers to impaired function of the spinal cord caused by degenerative changes of the cervical spine resulting in spinal cord compression. It is the most common disorder in the United States causing dysfunction of the spinal cord. A literature review of the natural history of mild cervical myelopathy is undertaken. Clinical presentation and current concepts of pathophysiology are also discussed. While many patients with mild signs of CSM will stabilize or improve over time with conservative treatment, the clinical course of a specific individual patient cannot be predicted. Asymptomatic patients with cervical stenosis and abnormalities on electrophysiologic studies may be at higher risk for developing myelopathy.

1 February 2015 in Journal of Neurosurgery
Verified
Journal Article
Open access
PDF file
JGJacob K. Greenberg
Jacob K. Greenberg
EMEric Milner
Eric Milner
CYChester K. Yarbrough
Chester K. Yarbrough
KLKim Lipsey
Kim Lipsey
JPJay F. Piccirillo
Jay F. Piccirillo
DLDavid D. Limbrick
David D. Limbrick
OBJECT: Chiari malformation Type I (CM-I) is a common and often debilitating neurological disease. Efforts to improve treatment of CM-I are impeded by inconsistent and limited methods of evaluating clinical outcomes. To understand current approaches and lay a foundation for future research, the authors conducted a systematic review of the methods used in original published research articles to evaluate clinical outcomes in patients treated for CM-I. METHODS: The authors searched PubMed, Embase, the Cumulative Index to Nursing and Allied Health Literature, ClinicalTrials.gov, and Cochrane databases to identify publications between January 2003 and August 2013 that met the following criteria: 1) reported clinical outcomes in patients treated for CM-I; 2) were original research articles; 3) included at least 10 patients or, if a comparative study, at least 5 patients per group; and 4) were restricted to patients with CM-I. RESULTS: Among the 74 papers meeting inclusion criteria, there was wide variation in the outcome methods used. However, all approaches were broadly grouped into 3 categories: 1) “gestalt” impression of overall symptomatic improvement (n = 45 papers); 2) postoperative change in specific signs or symptoms (n = 20); or 3) results of various standardized assessment scales (n = 22). Among standardized scales, 11 general function measures were used, compared with 6 disease-specific tools. Only 3 papers used scales validated in patients with CM-I. To facilitate a uniform comparison of these heterogeneous approaches, the authors appraised articles in multiple domains defined a priori as integral to reporting clinical outcomes in CM-I. Notably, only 7 articles incorporated patient-response instruments when reporting outcome, and only 22 articles explicitly assessed quality of life. CONCLUSIONS: The methods used to evaluate clinical outcomes in CM-I are inconsistent and frequently not comparable, complicating efforts to analyze results across studies. Development, validation, and incorporation of a small number of disease-specific patient-based instruments will improve the quality of research and care of CM-I patients.